Evaluation of the role of Methyltransferase 3 and the RNA-binding oncoprotein Musashi 2 as therapeutic targets in chronic lymphocytic leukemia
Preclinical evaluation of drugs with potential to activate the BMP9/10–ALK1–ENG–SMAD pathway for the treatment of hereditary haemorrhagic telangiectasia
Development of a pathogenicity score based on machine learning for the prioritisation of genomic variants in the context of medical genomics
